Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONGeneric

DEGARELIX ACETATE

DEGARELIX ACETATE

Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview DEGARELIX ACETATE is listed in Drugs@FDA under application 215791 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DEGARELIX ACETATE Form and strength NJECTION, POWDER, LYOPHILIZED, FOR SOLUTION - 80MG Sponsor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

Structured Monograph

Clinical summary

Approval overview DEGARELIX ACETATE is listed in Drugs@FDA under application 215791 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DEGARELIX ACETATE Form and strength NJECTION, POWDER, LYOPHILIZED, FOR SOLUTION - 80MG Sponsor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. Submission history Latest submission status date: 2025-08-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.